Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kathleen P. Mullinix & Associates is a boutique consulting firm providing strategic advisory services to the biotechnology and pharmaceutical industries. The firm is led by Dr. Kathleen P. Mullinix, a prominent figure in the biotech industry who previously founded and served as CEO of Synaptic Pharmaceutical Corporation. The consultancy focuses on corporate development, strategic planning, and management consulting for life science companies ranging from startups to established entities. Dr. Mullinix's extensive experience in GPCR research and corporate leadership informs the firm's approach to business and scientific strategy. The firm assists clients in navigating the complexities of drug discovery, regulatory pathways, and commercialization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kathleen P. Mullinix & Associates.